Study: New Test For Finding Drugs To Fight Persistent Lyme Disease
Potentially promising news on Lyme disease: Johns Hopkins researchers report a new, improved test for determining which drugs may work against Lyme disease bacteria that persist even after antibiotic treatment.
Continue Reading Here
An Optimized SYBR Green I/PI Assay for Rapid Viability Assessment and Antibiotic Susceptibility Testing for Borrelia burgdorferi
Lyme disease caused by Borrelia burgdorferi is the most common tick-borne disease in the US and Europe. Unlike most bacteria, measurements of growth and viability of B. burgdorferi are challenging. The current B. burgdorferi viability assays based on microscopic counting and PCR are cumbersome and tedious and cannot be used in a high throughput format.
See Abstract Here
This research was partially funded by Lymedisease.org. This is the kind of research our Lyme community desperately needs. So thank you to Lymedisease.org.
